Stock News and Filings Feed


Add LXX
to your dashboard

Lexaria Announces Upcoming Public Events and Warrant Exercise

35m accesswire
KELOWNA, BC / ACCESSWIRE / September 22, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces it will be attending and delivering a presentation at the upcoming Canadian Securities Exchange sponsored "Cannabis in the Capital Markets" event on September 27, in Kelowna, British Columbia. Also presenting at the event will be Dr. Philip Ainsle, Co-Director of the Centre for Heart, Lung and Vascular Health, UBC Okanagan Campus, Kelowna, Canada, who will be Principal Investigator of the previously announce clinical study to be conducted by UBC and Lexaria. (20-0)

NetworkNewsWire Announces Publication Highlighting Recent Developments in Drug Delivery Technologies

2017-09-20 marketwired
NEW YORK, NY--(Marketwired - Sep 20, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. (5-0)

Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects

2017-09-19 prnewswire
The hazards of pharmacology have hardly changed since Paracelsus, a famous Renaissance physician, astoundingly declared that it was only the dosage that separated a medicine from a poison, bundled with adverse side effects. Despite considerable advances in medicine, many medications are still as injurious as their Renaissance precursors. Nevertheless, recent developments in drug delivery technologies increasingly suggest that safer, more efficient treatment options are on the horizon. (49-0)

Latest Health Canada Report Is Good News For Licensed Producers

2017-09-15 seekingalpha
The number of registered patients rises to 201,398 or an increase of 20% in the last three months. This is the basic industry driver for Canadian cannabis companies. (0-1)

NetworkNewsWire Announces Publication Highlighting Companies Taking Innovative Strides in the Tobacco Industry

2017-08-17 marketwired
NEW YORK, NY--(Marketwired - Aug 17, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (CSE: LXX.CN) (CNSX: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids.

FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators

2017-08-16 prnewswire
The black cloud over Big Tobacco has been swirling for decades, but few developments have cast a bigger shadow than the U.S. Food and Drug Administration's recent proposal to reduce nicotine levels in cigarettes to non-addictive levels. The new plan[1], originally unveiled on July 28, is expected to serve as a multi-year roadmap aimed at saving lives and significantly reducing the effects of tobacco-related diseases.

Lexaria Announces Exercised Warrants and Options

2017-08-16 accesswire
KELOWNA, BC / ACCESSWIRE / August 16, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces it has received US$91,443.50 from the exercise of warrants and options previously granted. The stock warrants were exercised at the price of US$0.14 and the stock options were exercised at US$0.2273 for a total of 636,025 common shares being issued. All warrants and options are being exercised by third parties who are neither officers nor directors of the Company.

Lexaria Bioscience Corp. Engages NetworkNewsWire for Corporate Communications Solutions

2017-08-02 marketwired
NEW YORK, NY--(Marketwired - Aug 2, 2017) - Lexaria Bioscience Corp. ("the Company") (OTCQB: LXRP) (CSE: LXX), an innovative company licensing proprietary technology for delivery of bioactive compounds including cannabinoids, announces that it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

NetworkNewsWire Announces Publication Highlighting the Operations of Several Public Cannabis-Biotech Companies

2017-07-28 marketwired
NEW YORK, NY--(Marketwired - Jul 28, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids.

NeutriSci's Neuenergy(R) Launches in Quebec

2017-07-20 marketwired
VANCOUVER, BC--(Marketwired - July 20, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that neuenergy® is now available at Sobeys gas bars and convenience stores in Quebec.

National Research Council and Lexaria Bioscience Commence Laboratory Work

2017-07-20 marketwired
KELOWNA, BC--(Marketwired - July 20, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (CSE: LXX.CN) (CNSX: LXX) (the "Company" or "Lexaria") announces the start of laboratory work under its collaborative research program with the National Research Council of Canada ("NRC"), following the completion of preparation initiatives announced on March 14, 2017.

Lexaria Bioscience Awarded Australian Patent For Cannabinoid Infused Edibles

2017-07-19 marketwired
KELOWNA, BC--(Marketwired - July 18, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce that the Australian Patent Office has granted patent #2015274698 which protects Lexaria's method of improving absorption, speed of onset, and taste of cannabinoid active agents in edible products. The term of the patent is 20 years from June 10, 2015.

Health Canada Data Confirms Industry Trends

2017-07-14 seekingalpha
The increasing number of new medical marijuana patients in Canada continues to drive growth in the industry.

NeutriSci Announces Warrant Incentive Program

2017-07-07 marketwired
VANCOUVER, BC--(Marketwired - July 07, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce that it will immediately implement an incentive program designed to encourage the early exercise of up to 1,722,333 warrants issued on September 30, 2015 (the "September 2015 Warrants"); and 13,013,000 warrants issued on November 25, 2015 (the "November 2015 Warrants"); and the exercise of up to 2,220,000 warrants issued on July 25, 2016 (the "July 2016 Warrants"); and the exercise of up to 1,667,000 warrants issued on September 30, 2016 (the "September 2016 Warrants"); and the exercise of up to 15,000,000 warrants issued on November 18, 2016 (the "November 2016 Warrants"); and the exercise of up to 3,333,000 warrants issued on May 2, 2017 (the "May 2017 Warrants" and together with the September 2015, November 2015, July 2016, September 2016, and November 2016 Warrants, the "Original Warrants").

Lexaria Files New Patent Application

2017-06-22 marketwired
VANCOUVER, BC--(Marketwired - June 22, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces the filing of a new provisional patent application and stock and option awards.

NeutriSci Announces International Distribution Agreement and Initial Orders Into China, Hong Kong, Taiwan and Macau

2017-06-06 marketwired
VANCOUVER, BC--(Marketwired - June 06, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce its first major distribution agreement for neuenergy® into Greater China including Mainland China, Hong Kong, Taiwan and Macau.

NeutriSci Adds Esso Gas Bars and Convenience Stores to Its List of Canadian Retailers

2017-06-02 marketwired
VANCOUVER, BC--(Marketwired - June 01, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, announces its latest distribution agreement with Esso gas bars and convenience stores representing 150 stores in Saskatchewan, Alberta and British Columbia.

NeutriSci's Ambarii Corporation Announces LOI With Naturally Splendid to Distribute CBD Melts in Japan and South Korea

2017-05-30 marketwired
VANCOUVER, BC--(Marketwired - May 30, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) is pleased to announce that its joint venture subsidiary, Ambarii Trade Corporation ("Ambarii") and Naturally Splendid Enterprises Ltd. ("Naturally Splendid") have entered into a LOI for the sale and distribution of Ambarii's proprietary sublingual full spectrum hemp CBD tablets ("Ambarii CBD Tablets") in Japan and South Korea.

Lexaria's Ambarii Corporation Announces LOI With Naturally Splendid to Distribute CBD Melts in Japan and South Korea

2017-05-30 marketwired
VANCOUVER, BC--(Marketwired - May 30, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce that its 50%-owned joint venture subsidiary, Ambarii Trade Corporation ("Ambarii") has entered into a LOI with Naturally Splendid Enterprises Ltd. (TSX VENTURE: NSP) ("Naturally Splendid") for the production, sale and distribution of Ambarii's proprietary sublingual full spectrum hemp CBD tablets ("Ambarii CBD Tablets") in Japan and South Korea.

Lexaria raises US$1M from Warrant Exercise

2017-05-19 marketwired
KELOWNA, BC--(Marketwired - May 19, 2017) - Lexaria Bioscience Corp (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces it has received US$970,230.05 from the exercise of warrants previously granted. The stock warrants, which otherwise expired on May 15 2017, were exercised at the price of US$0.2273, for a total of 4,268,500 common shares being issued. All warrants are being exercised by third parties who are neither officers nor directors of the Company.

Lexaria Featured on Television

2017-05-18 accesswire
KELOWNA, BC / ACCESSWIRE / May 18, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is one of five companies featured on a special BTV episode exploring burgeoning cannabis enterprises.

Lexaria Announces Research on Nonsteroidal Anti-Inflammatory Drugs

2017-05-10 marketwired
KELOWNA, BC--(Marketwired - May 10, 2017) - Lexaria Bioscience Corp (OTCQB: LXRP) (CSE: LXX) (the "Company", "Lexaria") announces plans for research and formulation development ("R&D") on nonsteroidal anti-inflammatory drugs ("NSAIDs") utilizing its patented technology and as provisioned within its previously announced 2017 & 2018 R&D program.

Lexaria Announces R&D on Nicotine

2017-05-04 marketwired
KELOWNA, BC--(Marketwired - May 04, 2017) - Lexaria Bioscience Corp (OTCQB: LXRP) (CSE: LXX) (the "Company," "Lexaria") is announcing new plans to commence nicotine absorption research beginning in the summer of 2017, within its previously announced R&D budget that is fully funded.

Lexaria Announces Million Dollar Research and Development Program

2017-05-02 marketwired
KELOWNA, BC--(Marketwired - May 02, 2017) - Lexaria Bioscience Corp (OTCQB: LXRP) (CSE: LXX)(CSE: LXX.CN)(CNSX: LXX) (the "Company", "Lexaria") announces a $1 million combined research and development ("R&D") and intellectual property ("IP") budget.

Lexaria Welcomes Canada's Proposed Cannabis Legislation

2017-04-18 marketwired
KELOWNA, BC--(Marketwired - April 18, 2017) - Lexaria Bioscience Corp (OTCQB: LXRP) (CSE: LXX) (the "Company", "Lexaria") welcomes the newly proposed Canadian legislation designed to allow for adult legal access to Cannabis (the "Cannabis Act"). In line with the Cannabis Act's objective to protect public health and public safety, powerful demographic and lifestyle forces are trending away from both the harmful effects related to inhalational dosing (smoking/vaping) and from edibles with high sugar & fat content.